SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

US · Delayed Price · Currency is USD
5.49-0.29 (-5.02%)
 
Market Cap101.72M-59.1%
Revenue (ttm)0
Net Income-101.90M-75.8%
EPS-6.48-36.1%
Shares Out18.53M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,241,696
Open5.79
Previous Close5.78
Day's Range5.47 - 5.79
52-Week Range5.47 - 20.56
Beta2.63
AnalystsBuy
Price Target33.67(+513.30%)
Earnings DateNov 11, 2026
Insider Score
/ 100
CRBP Insider Score

Corbus Pharmaceuticals Holdings, Inc. has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock the score

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Address
500 River Ridge Drive, Norwood, MA, 02062, US
Market Cap
102 million
Employees
36
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.69M
Bought
$126.24K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-5.02%
5 Days
-16.69%
1 Month
-48.21%
6 Months
-44.21%
1 Year
-59.09%

$CRBP stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CRBP holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CRBP's directors and management

Net Shares Purchased by Insiders−80k−40k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CRBP Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CRBP Revenue by Segment

Reading latest SEC filing…

Source: SEC EDGAR (10-Q/10-K)

U.S. Patents

New CRBP patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CRBP from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CRBP

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$5.82M
IWMiShares Russell 2000 ETF$2.51M
VXFVanguard Extended Market ETF$2.16M
VTWOVanguard Russell 2000 ETF$1.03M
DFASDimensional - US Small Cap ETF$572.49K
FESMFidelity Enhanced Small Cap ETF$526.13K

Estimated from each fund’s disclosed top holdings × AUM

CRBP Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for CRBP is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from CRBP’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
3
Sells
17
Buy Value
$126.24K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.